Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

Latest News

NOT REAL NEWS: A look at what didn't happen this week

Jun 25, 2019

A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these is legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the real facts: ___ CLAIM: A photo shows a street intersection in Orlando shut down because of overflow crowds celebrating President Donald Trump's 2020 campaign launch Tuesday. THE FACTS: A photo described in Facebook posts as showing scores of Trump's supporters gathered outside his Tuesday night campaign rally in Orlando was actually taken a week ago in Toronto. The photo shows...

District 12 of 'The Hunger Games' is now a historic place

Jun 25, 2019

RALEIGH, N.C. — What would the folks in the Capitol think? District 12 is now on the National Register of Historic Places. The Henry River Mill Village, which served as the home of the three main characters from the original "The Hunger Games," was named a historic place last month and announced by state officials earlier this week. It's a designation that the new owners sought for the 72-acre (29-hectare) property because they "wanted to be the ones who got this property the recognition it deserves," said Calvin Reyes, who bought the village in 2017 with his mother and stepfather....

The Latest: Girl emotional, overwhelmed after Yosemite climb

Jun 25, 2019

SAN FRANCISCO — The Latest on a 10-year-old girl who climbed Yosemite's El Capitan (all times local): 3:15 p.m. A 10-year-old girl who climbed Yosemite National Park's famed El Capitan says she was overwhelmed and emotional when she reached the summit. Selah Schneiter said Wednesday she trained mentally and physically for nine months before climbing the challenging 3,000-foot (910 meters) granite wall with her father and a family friend. Schneiter, who is from Glenwood Springs, Colorado, says the only thing she feared was the possibility of a big storm when they had to go down the mountain. Selah and her...

US companies' message to Trump: Don't expand China tariffs

Jun 25, 2019

WASHINGTON — What happens if President Donald Trump carries out his threat to impose tariffs on the remaining $300 billion in Chinese goods that he hasn't already hit with 25% import taxes? A New Hampshire fireworks company says it would have to raise prices, likely lose business and force some small towns to cancel their Fourth of July fireworks displays. A Minnesota motorcycle maker warns that it would lose business to foreign rivals that don't have to pay taxes on Chinese parts. A Los Angeles designer and distributor of houseware goods says it would have to extend a hiring freeze...

Winker paces Reds with 5 RBIs in 11-3 rout over Rangers

Jun 25, 2019

CINCINNATI — With his dad set to leave town Sunday evening, Jesse Winker had limited time to provide an extra-special Father's Day. No worries — Joe Winker went to the airport with plenty to be proud of. Winker homered and set career highs with four hits and five RBIs, Yasiel Puig added a two-run shot, and the Cincinnati Reds beat the Texas Rangers 11-3 Sunday to avoid a three-game sweep. "It was really cool to have a good day on Father's Day," Winker said. "It was a cool weekend with my dad. We got to play some cards and smoke...

Search

About Us

Tale Out is your go-to website when it comes to global travel and lifestyle news. If you need suggestions for the most relaxing places for vacation or some zen spa retreat, we have it all here in Tale Out.

Contact us: sales@taleout.com